background

Tofacitinib Impurity A (citric acid)

Tofacitinib Impurity A (citric acid) Watermark

Tofacitinib Impurity A (citric acid)

CAT No:CL-TFC-115
CAS No:2174011-53-9
Mol.F:C16H20N6O : C6H8O7
Mol.Wt.:312.4 : 192.1
Chemical Name:3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
Inventory Status:Custom synthesis

This impurity is related to Tofacitinib Impurity A (citric acid) is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.

Tofacitinib Impurity A (citric acid) is used as a reference standard in analytical research. It ensures consistency of formulations.

Chemical Name:3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
Country of Origin: India
Product Category: Impurity Reference Standard
API NAME: Tofacitinib
Molecular Formula: C16H20N6O : C6H8O7
Molecular Weight: 312.4 : 192.1
Storage: Store in a cool, dry place.

Document